Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

novartis europharm limited - omalizumab - asthma; urticaria - drugs for obstructive airway diseases, - allergic asthmaxolair is indicated in adults, adolescents and children (6 to

Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

ge healthcare as  - regadenoson - myocardial perfusion imaging - cardiac therapy - this medicinal product is for diagnostic use only.rapiscan is a selective coronary vasodilator for use as a pharmacological stress agent for radionuclide myocardial perfusion imaging (mpi) in adult patients unable to undergo adequate exercise stress.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinylestradiol, quantity: 0.03 mg; levonorgestrel, quantity: 0.125 mg - tablet, sugar coated - excipient ingredients: glycerol; calcium carbonate; glycol montanate; purified talc; macrogol 6000; povidone; lactose monohydrate; iron oxide yellow; magnesium stearate; maize starch; titanium dioxide; sucrose - triphasil is indicated for the prevention of pregnancy.

Israel - Inggeris - Ministry of Health

cts ltd - progesterone micronized - capsules - progesterone micronized 200 mg - progesterone - progesterone - vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indication, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy. vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).

Israel - Inggeris - Ministry of Health

cts ltd - progesterone - capsules - progesterone 100 mg - progesterone - progesterone - vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indications, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinyloestradiol; levonorgestrel -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinyloestradiol; gestodene -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinyloestradiol; levonorgestrel -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinyloestradiol; levonorgestrel -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinyloestradiol; levonorgestrel -